Increased Bone Mass in Female Mice Lacking Mast Cell Chymase
暂无分享,去创建一个
H. Melhus | Lijuan Hu | S. Larsson | M. Åbrink | G. Pejler | T. Lind | G. Andersson | K. Jonsson | S. Wernersson | A. Gustafson | A. Rasmusson | G. Calounova
[1] M. Iglarz,et al. Endothelin receptor antagonist macitentan or deletion of mouse mast cell protease 4 delays lesion development in atherosclerotic mice. , 2016, Life sciences.
[2] M. MacDougall,et al. Establishment of Immortalized BMP2/4 Double Knock‐Out Osteoblastic Cells Is Essential for Study of Osteoblast Growth, Differentiation, and Osteogenesis , 2015, Journal of cellular physiology.
[3] G. Pejler,et al. The Role of Mast Cells in Bacterial Infection. , 2016, American Journal of Pathology.
[4] K. Michaëlsson,et al. Osteoporosis: the emperor has no clothes , 2015, Journal of internal medicine.
[5] M. Tsai,et al. Approaches for analyzing the roles of mast cells and their proteases in vivo. , 2015, Advances in immunology.
[6] L. Idolazzi,et al. Bone involvement and osteoporosis in mastocytosis. , 2014, Immunology and allergy clinics of North America.
[7] Piero Carninci,et al. Redefinition of the human mast cell transcriptome by deep-CAGE sequencing. , 2014, Blood.
[8] T. Vangansewinkel,et al. Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4 , 2014, Neurobiology of Disease.
[9] Susan M. Schlenner,et al. Mast Cell Chymase Degrades the Alarmins Heat Shock Protein 70, Biglycan, HMGB1, and Interleukin-33 (IL-33) and Limits Danger-induced Inflammation* , 2013, The Journal of Biological Chemistry.
[10] C. Cooper,et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden , 2013, Archives of Osteoporosis.
[11] G. Pejler,et al. Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation , 2012, Mucosal Immunology.
[12] D. Voehringer. Protective and pathological roles of mast cells and basophils , 2013, Nature Reviews Immunology.
[13] S. Hendrix,et al. Mast cells protect from post‐traumatic brain inflammation by the mast cell‐specific chymase mouse mast cell protease‐4 , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] E. Schwarz,et al. PTH‐enhanced structural allograft healing is associated with decreased angiopoietin‐2–mediated arteriogenesis, mast cell accumulation, and fibrosis , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[15] M. Amling,et al. Increased osteoblast and osteoclast indices in individuals with systemic mastocytosis , 2013, Osteoporosis International.
[16] G. Shi,et al. Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases. , 2012, Current pharmaceutical design.
[17] O. Hermine,et al. Bone complications of mastocytosis: a link between clinical and biological characteristics. , 2013, The American journal of medicine.
[18] H. Kluin-Nelemans,et al. High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis , 2012, Allergy.
[19] Microarray Profiling of Diaphyseal Bone of Rats Suffering from Hypervitaminosis A , 2012, Calcified Tissue International.
[20] G. Passalacqua,et al. Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. , 2011, Bone.
[21] T. Garland,et al. Identification of quantitative trait loci influencing skeletal architecture in mice: Emergence of Cdh11 as a primary candidate gene regulating femoral morphology , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] Z. Werb,et al. Dual Targets for Mouse Mast Cell Protease-4 in Mediating Tissue Damage in Experimental Bullous Pemphigoid* , 2011, The Journal of Biological Chemistry.
[23] J. Nyman,et al. Differential effects between the loss of MMP‐2 and MMP‐9 on structural and tissue‐level properties of bone , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[24] H. Melhus,et al. High dietary intake of retinol leads to bone marrow hypoxia and diaphyseal endosteal mineralization in rats. , 2011, Bone.
[25] T. V. van Berkel,et al. Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-/- mice. , 2011, Cardiovascular research.
[26] R. Civitelli,et al. N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms , 2010, Journal of Cell Science.
[27] E. Daugas,et al. Mouse Mast Cell Protease-4 Deteriorates Renal Function by Contributing to Inflammation and Fibrosis in Immune Complex-Mediated Glomerulonephritis , 2010, The Journal of Immunology.
[28] Gunnar Pejler,et al. Mast cell proteases: multifaceted regulators of inflammatory disease. , 2010, Blood.
[29] W. Abraham,et al. Dual inhibition of cathepsin G and chymase is effective in animal models of pulmonary inflammation. , 2010, American journal of respiratory and critical care medicine.
[30] R. Turner,et al. The Role of Mast Cells in Parathyroid Bone Disease , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[31] F. Finkelman,et al. Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism , 2009, Proceedings of the National Academy of Sciences.
[32] P. Libby,et al. Critical Role of Mast Cell Chymase in Mouse Abdominal Aortic Aneurysm Formation , 2009, Circulation.
[33] S. Khosla. Increasing options for the treatment of osteoporosis. , 2009, New England Journal of Medicine.
[34] S. Knight,et al. Novel insights into the biological function of mast cell carboxypeptidase A. , 2009, Trends in immunology.
[35] M. Åbrink,et al. Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] L. Hellman,et al. Serglycin proteoglycan is required for secretory granule integrity in mucosal mast cells. , 2007, The Biochemical journal.
[37] S. Itohara,et al. A Crucial Role for Matrix Metalloproteinase 2 in Osteocytic Canalicular Formation and Bone Metabolism* , 2006, Journal of Biological Chemistry.
[38] B. Gruber,et al. The role of mast cells in osteoporosis. , 2006, Seminars in arthritis and rheumatism.
[39] J. Saffar,et al. Time-course of mast cell accumulation in rat bone marrow after ovariectomy , 2001, Calcified Tissue International.
[40] Y. Konttinen,et al. Mast cells in atherosclerosis as a source of the cytokine RANKL , 2006, Clinical chemistry and laboratory medicine.
[41] B. Premack,et al. Proteolytic Activation of Alternative CCR1 Ligands in Inflammation1 , 2005, The Journal of Immunology.
[42] M. Åbrink,et al. A Key Role for Mast Cell Chymase in the Activation of Pro-matrix Metalloprotease-9 and Pro-matrix Metalloprotease-2* , 2005, Journal of Biological Chemistry.
[43] F. Islam,et al. Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. , 2005, Bone.
[44] D. Mooney,et al. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4) , 2005, Gene Therapy.
[45] Wei Zhao,et al. Cytokine production by skin-derived mast cells: endogenous proteases are responsible for degradation of cytokines. , 2005, Journal of immunology.
[46] M. Tsai,et al. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. , 2005, Annual review of immunology.
[47] H. Chen,et al. Ultrastructural changes in bones of the senescence-accelerated mouse (SAMP6): a murine model for senile osteoporosis. , 2004, Histology and histopathology.
[48] S. Takai,et al. A Specific Chymase Inhibitor, 2-(5-Formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), Suppresses Development of Abdominal Aortic Aneurysm in Hamsters , 2004, Journal of Pharmacology and Experimental Therapeutics.
[49] M. Åbrink,et al. The Chymase, Mouse Mast Cell Protease 4, Constitutes the Major Chymotrypsin-like Activity in Peritoneum and Ear Tissue. A Role for Mouse Mast Cell Protease 4 in Thrombin Regulation and Fibronectin Turnover , 2003, The Journal of experimental medicine.
[50] K. Arakawa,et al. Chymase Inhibitor Improves Survival in Hamsters with Myocardial Infarction , 2003, Journal of cardiovascular pharmacology.
[51] S. Takai,et al. Oral administration of a novel chymase inhibitor, NK3201, prevents peritoneal adhesion formation in hamsters. , 2002, Japanese journal of pharmacology.
[52] M. Miyazaki,et al. Therapeutic potential of a specific chymase inhibitor in atopic dermatitis. , 2002, Japanese journal of pharmacology.
[53] L. Thompson,et al. Mast cell involvement in fibrodysplasia ossificans progressiva. , 2001, Human pathology.
[54] B. Julian,et al. Expression of stem cell factor by osteoblasts in normal and hyperparathyroid bone: relation to ectopic mast cell differentiation , 1999, Virchows Archiv.
[55] G. Andersson,et al. Comparative studies of rat recombinant purple acid phosphatase and bone tartrate-resistant acid phosphatase. , 1997, The Biochemical journal.
[56] H. Neurath,et al. Mast cell proteases. , 1981, Methods in enzymology.
[57] E. Storey,et al. LOW‐CALCIUM/HIGH PHOSPHORUS RICKETS IN RATS. I. MAST CELL CHANGES , 1979, Pathology.